Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials

INTRODUCTION: Ventilator-associated pneumonia (VAP) is reported as the second most common nosocomial infection among critically ill patients with the incidence ranging from 2 to 16 episodes per 1000 ventilator days. The use of probiotics has been shown to have a promising effect in many RCTs. Our sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Priyam, Soni, Kapil Dev, Mathur, Purva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561245/
https://www.ncbi.nlm.nih.gov/pubmed/33082958
http://dx.doi.org/10.1186/s40560-020-00487-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561245/
https://www.ncbi.nlm.nih.gov/pubmed/33082958
http://dx.doi.org/10.1186/s40560-020-00487-8

Ejemplares similares